|
1.
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: from genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Yang HI, Lu SN, Liaw YF, et al: Hepatitis
B e antigen and the risk of hepatocellular carcinoma. N Engl J Med.
347:168–174. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
4.
|
Llovet JM: Updated treatment approach to
hepatocellular carcinoma. J Gastroenterol. 40:225–235. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Cabibbo G, Enea M, Attanasio M, Bruix J,
Craxi A and Camma C: A meta-analysis of survival rates of untreated
patients in randomized clinical trials of hepatocellular carcinoma.
Hepatology. 51:1274–1283. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Kim JH, Yoon HK, Kim SY, et al:
Transcatheter arterial chemoembolization vs. chemoinfusion for
unresectable hepatocellular carcinoma in patients with major portal
vein thrombosis. Aliment Pharmacol Ther. 29:1291–1298. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kothary N, Weintraub JL, Susman J and
Rundback JH: Transarterial chemoembolization for primary
hepatocellular carcinoma in patients at high risk. J Vasc Interv
Radiol. 18:1517–1527. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Chung YH, Song IH, Song BC, et al:
Combined therapy consisting of intraarterial cisplatin infusion and
systemic interferon-alpha for hepatocellular carcinoma patients
with major portal vein thrombosis or distant metastasis. Cancer.
88:1986–1991. 2000. View Article : Google Scholar
|
|
9.
|
Obi S, Yoshida H, Toune R, et al:
Combination therapy of intraarterial 5-fluorouracil and systemic
interferon-alpha for advanced hepatocellular carcinoma with portal
venous invasion. Cancer. 106:1990–1997. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Emami B, Lyman J, Brown A, et al:
Tolerance of normal tissue to therapeutic irradiation. Int J Radiat
Oncol Biol Phys. 21:109–122. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Krishnan S, Dawson LA, Seong J, et al:
Radiotherapy for hepatocellular carcinoma: an overview. Ann Surg
Oncol. 15:1015–1024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Price TR, Perkins SM, Sandrasegaran K, et
al: Evaluation of response after stereotactic body radiotherapy for
hepatocellular carcinoma. Cancer. 118:3191–3198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Facciuto ME, Singh MK, Rochon C, et al:
Stereotactic body radiation therapy in hepatocellular carcinoma and
cirrhosis: evaluation of radiological and pathological response. J
Surg Oncol. 105:692–698. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Tse RV, Hawkins M, Lockwood G, et al:
Phase I study of individualized stereotactic body radiotherapy for
hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J
Clin Oncol. 26:657–664. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Choi BO, Choi IB, Jang HS, et al:
Stereotactic body radiation therapy with or without transarterial
chemoembolization for patients with primary hepatocellular
carcinoma: preliminary analysis. BMC Cancer. 8:3512008. View Article : Google Scholar
|
|
16.
|
Zhao M, Wang JP, Li W, et al: Comparison
of safety and efficacy for transcatheter arterial chemoembolization
alone and plus radiofrequency ablation in the treatment of single
branch portal vein tumor thrombus of hepatocellular carcinoma and
their prognosis factors. Zhonghua Yi Xue Za Zhi. 91:1167–1172.
2011.(In Chinese).
|
|
17.
|
Dawson LA, Eccles C and Craig T:
Individualized image guided iso-NTCP based liver cancer SBRT. Acta
Oncol. 45:856–864. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Lawrence TS, Robertson JM, Anscher MS,
Jirtle RL, Ensminger WD and Fajardo LF: Hepatic toxicity resulting
from cancer treatment. Int J Radiat Oncol Biol Phys. 31:1237–1248.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Lo SS, Dawson LA, Kim EY, et al:
Stereotactic body radiation therapy for hepatocellular carcinoma.
Discov Med. 9:404–410. 2010.PubMed/NCBI
|
|
20.
|
Sawrie SM, Fiveash JB and Caudell JJ:
Stereotactic body radiation therapy for liver metastases and
primary hepatocellular carcinoma: normal tissue tolerances and
toxicity. Cancer Control. 17:111–119. 2010.PubMed/NCBI
|
|
21.
|
Izaki K, Sugimoto K, Sugimura K and Hirota
S: Transcatheter arterial embolization for advanced tumor thrombus
with marked arterioportal or arteriovenous shunt complicating
hepatocellular carcinoma. Radiat Med. 22:155–162. 2004.
|
|
22.
|
Li Q, Zeng CJ and Wang Y: Interventional
chemoembolization combined with proton radiotherapy for the
treatment of hepatocellular carcinoma accompanied with portal
cancerous thrombus. J Intervent Radiol. 18:278–280. 2009.
|
|
23.
|
Seong J, Park HC, Han KH, et al: Clinical
results of 3-dimensional conformal radiotherapy combined with
transarterial chemoembolization for hepatocellular carcinoma in the
cirrhotic patients. Hepatol Res. 27:30–35. 2003. View Article : Google Scholar
|
|
24.
|
Ren B, Song JB, Wang XD, et al:
Stereotactic radiotherapy for hepatocellular carcinoma with portal
tumor thrombi. Chin J Hepatol. 14:308–309. 2006.(In Chinese).
|
|
25.
|
Dang YZ, Zhang XC, Lu WL, et al: Body
gamma knife and high intensity focused ultrasound (HIFU) for the
treatment of portal vein tumor thrombosis of hepatocellular
carcinoma. J Mod Oncol. 18:114–117. 2010.
|
